BIO Token Rises 40% Following Upbit Exchange Listing News
Bio Protocol (BIO) experienced a 40% rally on October 20, reaching an intraday high of $0.11, with a trading volume surge of 350% to nearly $136 million. This was driven by its listing on Upbit, South Korea's largest crypto exchange.
- Upbit will list BIO across KRW, BTC, and USDT markets, starting at 6:00 p.m. KST on October 20.
- Initial trading includes a ±10% price band for the first five minutes and a two-hour limit on certain order types.
- BIO's market cap increased by 40%, placing it among the top 200 cryptocurrencies.
Bio Protocol Overview
Bio Protocol is a decentralized science initiative aimed at transforming biotech research via blockchain, allowing tokenization of intellectual property and community governance through DAOs. It has been recognized by major exchanges, including Binance, Coinbase, and Bithumb.
The platform launched Bio Launchpad recently, attracting over 8,000 participants to its initial projects.
BIO Price Analysis
- The 4-hour chart shows overbought conditions; potential short-term pullback if the price fails to sustain $0.10.
- MACD indicators suggest continued upward momentum, with resistance near $0.125, potentially extending to $0.15.
- BIO remains 88% below its all-time high of $0.9226 from January.
PEPENODE Funding and Tokenomics
PEPENODE raised $1.88 million during its presale. The project aims to make crypto mining accessible and engaging through a game-like experience without the need for expensive setups.
- Developed on Ethereum, PEPENODE uses a deflationary token model with a significant portion burned to reduce supply.
- Presale offers early backers up to 680% in staking returns.